Literature DB >> 15115383

Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.

Ruengwit Kitbunnadaj1, Obbe P Zuiderveld, Bernard Christophe, Saskia Hulscher, Wiro M P B Menge, Edith Gelens, Erwin Snip, Remko A Bakker, Sylvain Celanire, Michel Gillard, Patrice Talaga, Henk Timmerman, Rob Leurs.   

Abstract

In this study, the piperidine ring of immepip and its analogues was replaced by a rigid heterocyclic pyridine ring. Many compounds in the series exhibit high affinity and agonist activity at the human histamine H(3) receptor. Particularly, the 4-pyridinyl analogue of immepip (1c, immethridine) is identified as a novel potent and highly selective histamine H(3) receptor agonist (pK(i) = 9.07, pEC(50) = 9.74) with a 300-fold selectivity over the closely related H(4) receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115383     DOI: 10.1021/jm049932u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Metal-free carbon-carbon bond-forming reductive coupling between boronic acids and tosylhydrazones.

Authors:  José Barluenga; María Tomás-Gamasa; Fernando Aznar; Carlos Valdés
Journal:  Nat Chem       Date:  2009-08-16       Impact factor: 24.427

3.  Efficient library synthesis of imidazoles using a multicomponent reaction and microwave irradiation.

Authors:  E Gelens; F J J De Kanter; R F Schmitz; L A J M Sliedregt; B J Van Steen; Chris G Kruse; R Leurs; M B Groen; R V A Orru
Journal:  Mol Divers       Date:  2006-02       Impact factor: 2.943

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

5.  Synthesis and biological evaluation of aminothiazoles against Histoplasma capsulatum and Cryptococcus neoformans.

Authors:  Keisuke Ishita; Stavros Stefanopoulos; Ahmed Khalil; Xiaolin Cheng; Werner Tjarks; Chad A Rappleye
Journal:  Bioorg Med Chem       Date:  2018-02-02       Impact factor: 3.641

6.  Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells.

Authors:  Jillian G Baker
Journal:  BMC Pharmacol       Date:  2008-06-06

7.  Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells.

Authors:  Yaru Shi; Zhenlong Li; Ran Chen; Jiang Zhang; Xuefei Hu; Cong He; Qiong Su; Hongdou Ma; Hua Ren; Min Qian; Shufang Cui; Wenzheng Jiang
Journal:  Oncotarget       Date:  2017-08-24

8.  Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming.

Authors:  Kazuyuki Noguchi; Junji Ishida; Jun-Dal Kim; Naoto Muromachi; Koichiro Kako; Hayase Mizukami; Weizhe Lu; Tomohiro Ishimaru; Shohei Kawasaki; Shuzo Kaneko; Joichi Usui; Hiroshi Ohtsu; Kunihiro Yamagata; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

9.  Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives.

Authors:  Gustavo Provensi; Alessio Nocentini; Maria Beatrice Passani; Patrizio Blandina; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity.

Authors:  Gábor Wágner; Tamara A M Mocking; Marta Arimont; Gustavo Provensi; Barbara Rani; Bruna Silva-Marques; Gniewomir Latacz; Daniel Da Costa Pereira; Christina Karatzidou; Henry F Vischer; Maikel Wijtmans; Katarzyna Kieć-Kononowicz; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2019-11-20       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.